Gene mutations help predict outcomes for hard-to-diagnose blood cancer

Researchers identified genetic markers that predict survival in acute myeloid leukemia patients whose cancers defy standard diagnostic tests. The findings could guide treatment decisions and stem cell transplant timing for a patient population that currently lacks clear clinical roadmaps, potentially improving outcomes and reducing costly trial-and-error approaches.

Originaltitel: Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis